Regional expansion Candela is actively expanding leadership and presence in Europe, with new UK and Iberia leadership appointments and partnerships. This indicates opportunities to align regional service, training, and channel programs, as well as cross-border sales of advanced laser platforms.

Clinical validation Recent in vivo human evidence on Nordlys 1940 nm laser modulation published with Mitra Bio reinforces the efficacy of Candela’s non-ablative fractional technology. This supports targeting clinics prioritizing proven outcomes and can drive premium product discussions and education commitments.

New platform momentum Launch of Glacē facial system and ongoing promotion of GentleLASE, GentleMax Pro Plus, and Matrix platforms signal a multi-platform strategy. There are cross-sell and upgrade opportunities for clinics adopting new facial rejuvenation and hair removal capabilities.

Customer experience focus Partnership with Verde Group to study customer experience indicates a data-driven approach to growth and retention. This creates sales angles around improving clinic efficiency, patient throughput, and long-term device service value.

Prestige partnerships Sponsorships and collaborations with high-end aesthetics events and renowned clinics (Bellisimospa, Maison Zolara, The Aesthetics Awards) reflect brand prestige and influence among leading practices, suggesting opportunity to target top-tier accounts with premium solutions and training programs.